FDAnews
www.fdanews.com/articles/134535-vertex-shares-soar-on-cystic-fibrosis-drug-data

Vertex Shares Soar on Cystic Fibrosis Drug Data

February 23, 2011
An experimental drug made by Vertex Pharmaceuticals Inc. significantly improved lung function in patients with cystic fibrosis, sending the company’s shares up 18 percent to a four-year high.
CNBC